Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
Status: Open
- Who can apply
- Nonprofits, small businesses, state, local and tribal governments, tribes, schools and universities, for-profit companies, others.
- Deadline
- Friday, November 16, 2029 - check the notice for the exact time
- Opened Nov 3, 2026
- Amount
- Not stated by the source
- Official source
- Read and apply at the official source Found on grants.gov
- Requirements
- Documents with the official notice: PAR-28-042-Full-Announcement.html
- Organizations need a SAM.gov ID number (UEI) to apply. Individuals do not.
- Application fee
- We do not read fees from notices; check the official notice. GrantsWindow never charges you.
- Funder
- National Institutes of Health (federal)
- Assistance Listing 93.CA1
- Last checked
- Checked Nov 15, 2026 at the official source
From the official notice
The purpose of the Notice of Funding Opportunity (NOFO) is to support the analytical and clinical validation of molecular, cellular, and imaging biomarkers and assays for cancer detection, diagnosis, prognosis, monitoring, prediction of response or resistance to treatment, cancer prevention and ...